Outside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's treatment donanemab outweighed its risks, and agreed that ...
Rouche, a global healthcare company headquartered in Basel, Switzerland, announced Sunday that the U.S. Food and Drug Administration granted approval to its Elecsys Phospho-Tau blood test for ...
The PrecivityAD2 test can screen adults decades before Alzheimer’s is typically diagnosed.